| Aug 8 |
Agenus Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 8 |
Agenus (AGEN) Reports Q2 Loss, Lags Revenue Estimates
|
| Aug 8 |
Agenus GAAP EPS of -$2.52 misses by $1.19, revenue of $23.51M misses by $39.97M
|
| Aug 8 |
Agenus: Q2 Earnings Snapshot
|
| Aug 8 |
Agenus Reports Second Quarter 2024 Operational and Financial Results
|
| Aug 8 |
Agenus Announces Appointment of Tom Harrison to Board of Directors
|
| Aug 7 |
Agenus Q2 2024 Earnings Preview
|
| Aug 7 |
Agenus Publishes Seminal Study on Botensilimab’s Activity in Treatment-Resistant Cancers
|
| Aug 5 |
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
|
| Aug 5 |
Bristol Myers sends TIGIT drug back to Agenus
|
